Dr Anthony Luke Byrne
Conjoint Senior Lecturer

Dr Anthony Luke Byrne

PhD MBBS MIPH BAppSc FRACP

medicine-health
St Vincent's Clinical School

Dr Anthony Byrne is a thoracic physician and researcher with a strong interest in respiratory infections, asthma and structural lung disease. His doctoral studies focused on the link between tuberculosis and chronic respiratory disease including asthma and chronic obstructive pulmonary disease among patients in Lima, Peru.

Dr Byrne is a staff specialist respiratory physician at St Vincent’s public and private hospitals and has consulting rooms at St Vincent’s Clinic, Darlinghurst. He is a Cochrane author and associate editor with the “Cochrane Clinical Answers” initiative, dedicated to providing bite-size, clinician-focused summaries of high-quality systematic reviews. 

 

Current Positions 
    

Staff Specialist in Respiratory Medicine, St Vincent’s Public and Private Hospitals, Sydney. 

Staff Specialist in Respiratory Medicine, Blacktown Public Hospital, Sydney.


Conjoint Associate Lecturer of Medicine: St Vincent’s Clinical School, UNSW.


Author, Cochrane Clinical Answers, Cochrane Review Group 

Respiratory Physician: St Vincent’s Clinic suite 806, Victoria St, Sydney (Private Practice) 
 

Phone
+612 83826822
Location
Dr Anthony Byrne PhD MBBS MIPH BAppSc FRACP Staff Specialist Thoracic Physician Staff specialist St Vincent's and Blacktown Hospitals, Sydney Australia. Respiratory Physician St Vincent's Clinic, Suite 806 Level 8, Darlinghurst. Principal Investigator Socios En Salud, Partners In Health Peru.

Publications

  • Book Chapters | 2021
    Dr Anthony Luke Byrne
    Alffenaar J-WC; Kim HY; Byrne A; Piubello A; Migliori GB, 2021, 'Monitoring Treatment: Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis', in Essential Tuberculosis, Springer International Publishing, pp. 163 - 170, http://dx.doi.org/10.1007/978-3-030-66703-0_18
  • Journal articles | 2021
    Dr Anthony Luke Byrne
    Darley D; Matthews G; Dore G; Wilhelm K; Plit M; Stone E; Byrne A; Tonga K; Andresen D; Kelleher A; Cysique L; Cunningham P; Brew B, 2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963
    Journal articles | 2021
    Dr Anthony Luke Byrne
    Alffenaar JW; Märtson AG; Heysell SK; Cho JG; Patanwala A; Burch G; Kim HY; Sturkenboom MGG; Byrne A; Marriott D; Sandaradura I; Tiberi S; Sintchencko V; Srivastava S; Peloquin CA, 2021, 'Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections', Clinical Pharmacokinetics, vol. 60, pp. 711 - 725, http://dx.doi.org/10.1007/s40262-021-01000-6
    Journal articles | 2021
    Dr Anthony Luke Byrne
    Joseph Y; Yao Z; Dua A; Severe P; Collins SE; Bang H; Antoine Jean-Juste M; Ocheretina O; Apollon A; McNairy ML; Dupnik K; Cremieux E; Byrne A; Pape JW; Koenig SP, 2021, 'Long-term mortality after tuberculosis treatment among persons living with HIV in Haiti', Journal of the International AIDS Society, vol. 24, pp. e25721, http://dx.doi.org/10.1002/jia2.25721
    Journal articles | 2021
    Dr Anthony Luke Byrne
    Allwood BW; Byrne A; Meghji J; Rachow A; Van Der Zalm MM; Schoch OD, 2021, 'Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge', Respiration, http://dx.doi.org/10.1159/000512531
    Journal articles | 2020
    Dr Anthony Luke Byrne
    Allwood BW; Van Der Zalm MM; Amaral AFS; Byrne A; Datta S; Egere U; Evans CA; Evans D; Gray DM; Hoddinott G; Ivanova O; Jones R; Makanda G; Marx FM; Meghji J; Mpagama S; Pasipanodya JG; Rachow A; Schoeman I; Shaw J; Stek C; Van Kampen S; Von Delft D; Walker NF; Wallis RS; Mortimer K, 2020, 'Post-tuberculosis lung health: Perspectives from the First International Symposium', International Journal of Tuberculosis and Lung Disease, vol. 24, pp. 820 - 828, http://dx.doi.org/10.5588/ijtld.20.0067
    Journal articles | 2020
    Dr Anthony Luke Byrne
    Yeong C; Byrne AL; Cho JG; Sintchenko V; Crighton T; Marais BJ, 2020, 'Use of GeneXpert MTB/RIF on a single pooled sputum specimen to exclude pulmonary tuberculosis among hospital inpatients placed in respiratory isolation', International Journal of Infectious Diseases, vol. 92, pp. 175 - 180, http://dx.doi.org/10.1016/j.ijid.2019.12.024
    Journal articles | 2020
    Dr Anthony Luke Byrne
    Robertson DJ; Sanders JG; Towler A; Kramer RSS; Spowage J; Byrne A; Burton AM; Jenkins R, 2020, 'Hyper-realistic Face Masks in a Live Passport-Checking Task', Perception, vol. 49, pp. 298 - 309, http://dx.doi.org/10.1177/0301006620904614
    Journal articles | 2020
    Dr Anthony Luke Byrne
    Byrne AL; Bennett MH; Chatterji R; Symons R; Thomas PS, 2020, 'Arterial and venous blood gases in exacerbations of chronic obstructive pulmonary disease', Internal Medicine Journal, vol. 50, pp. 133 - 134, http://dx.doi.org/10.1111/imj.14692
    Journal articles | 2020
    Dr Anthony Luke Byrne
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G, 2020, 'Burden of non-communicable diseases from infectious causes in 2017: a modelling study', The Lancet Global Health, vol. 8, pp. e1489 - e1498, http://dx.doi.org/10.1016/S2214-109X(20)30358-2
    Journal articles | 2019
    Dr Anthony Luke Byrne
    Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2019, 'Asthma and atopy prevalence are not reduced among former tuberculosis patients compared with controls in Lima, Peru', BMC Pulmonary Medicine, vol. 19, pp. 40, http://dx.doi.org/10.1186/s12890-019-0804-z
    Journal articles | 2018
    Dr Anthony Luke Byrne
    Byrne AL; Fox GJ; Marais BJ, 2018, 'Better than a pound of cure: Preventing the development of multidrug-resistant tuberculosis', Future Microbiology, vol. 13, pp. 577 - 588, http://dx.doi.org/10.2217/fmb-2017-0236
    Journal articles | 2018
    Dr Anthony Luke Byrne
    Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2018, 'Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru', International Journal of Tuberculosis and Lung Disease, vol. 22, pp. 86 - 92, http://dx.doi.org/10.5588/ijtld.17.0381
    Journal articles | 2017
    Dr Anthony Luke Byrne
    Hovey EJ; Field KM; Rosenthal MA; Barnes EH; Cher L; Nowak AK; Wheeler H; Sawkins K; Livingstone A; Phal P; Goh C; Simes J; Kelly P; Hayden A; Barnes E; Espinoza D; Brown C; Winter D; Tomes B; Pike R; Simes J; Garrett L; Kilsby H; Freilich R; Arzhintar I; Dowling A; Ranieri N; Jennens R; Osmond F; Patterson KW; Phay A; Byrne A; Begbie S; Williams P; Kirby-Lewis S; Abell F; Plowman L; Flynn J; Inglis P; Ives A; Lobb S; Lwin Z; Woodward N; Crosbie G; Singhal N; Smith S; Whelan M, 2017, 'Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: An exploratory randomized phase II trial', Neuro-Oncology Practice, vol. 4, pp. 171 - 181, http://dx.doi.org/10.1093/nop/npw025
    Journal articles | 2017
    Dr Anthony Luke Byrne
    Ho J; Byrne AL; Linh NN; Jaramillo E; Fox GJ, 2017, 'Decentralized care for multidrug-resistant tuberculosis: A systematic review and meta-analysis', Bulletin of the World Health Organization, vol. 95, pp. 584 - 593, http://dx.doi.org/10.2471/BLT.17.193375
    Journal articles | 2017
    Dr Anthony Luke Byrne
    Byrne AL; Marais BJ; Mitnick CD; Garden FL; Lecca L; Contreras C; Yauri Y; Garcia F; Marks GB, 2017, 'Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis', ERS Monograph, vol. 3, http://dx.doi.org/10.1183/23120541.00026-2017
    Journal articles | 2017
    Dr Anthony Luke Byrne
    Hayman YA; Sadofsky LR; Williamson JD; Hart SP; Morice AH, 2017, 'The effects of exogenous lipid on THP-1 cells: an in vitro model of airway aspiration?', ERJ Open Res, vol. 3, http://dx.doi.org/10.1183/23120541.00026-2016
    Journal articles | 2015
    Dr Anthony Luke Byrne
    Field KM; Simes J; Nowak AK; Cher L; Wheeler H; Hovey EJ; Brown CSB; Barnes EH; Sawkins K; Livingstone A; Freilich R; Phal PM; Fitt G; Rosenthal MA; Arzhintar I; Garrett L; Byrne A; Dowling A; Ranieri N; Jennens R; Osmond F; Patterson WK; Phay A; Abell F; Plowman L; Flynn J; Hovey E; Kilsby H; Kirby-Lewis S; Singhal N; Smith S; Whelan M; Inglis P; Ives A; Nowak A; Lobb S; Begbie S; Williams P; Lwin Z; Woodward N; Crosbie G; Harrup R; Pyszkowski L; Gauden S; Neville A, 2015, 'Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma', Neuro-Oncology, vol. 17, pp. 1504 - 1513, http://dx.doi.org/10.1093/neuonc/nov104
    Journal articles | 2015
    Dr Anthony Luke Byrne
    Byrne AL; Marais BJ; Mitnick CD; Lecca L; Marks GB, 2015, 'Tuberculosis and chronic respiratory disease: A systematic review', International Journal of Infectious Diseases, vol. 32, pp. 138 - 146, http://dx.doi.org/10.1016/j.ijid.2014.12.016
    Journal articles | 2015
    Dr Anthony Luke Byrne
    Byrne AL; Marais BJ; Mitnick CD; Lecca L; Marks GB, 2015, 'Risk factors for and origins of COPD', The Lancet, vol. 385, pp. 1723 - 1724, http://dx.doi.org/10.1016/S0140-6736(15)60884-4
    Journal articles | 2014
    Dr Anthony Luke Byrne
    Byrne AL; Bennett M; Chatterji R; Symons R; Pace NL; Thomas PS, 2014, 'Peripheral venous and arterial blood gas analysis in adults: Are they comparable? A systematic review and meta-analysis', Respirology, vol. 19, pp. 168 - 175, http://dx.doi.org/10.1111/resp.12225
    Journal articles | 2014
    Dr Anthony Luke Byrne
    Byrne A; Bennett M; Chatterji R; Symons R; Pace N; Thomas P, 2014, 'Comparison of peripheral venous and arterial blood gas analyses Reply', RESPIROLOGY, vol. 19, pp. 769 - 770, http://dx.doi.org/10.1111/resp.12300
    Journal articles | 2014
    Dr Anthony Luke Byrne
    Byrne A; Bennett M; Chatterji R; Symons R; Pace N; Thomas P, 2014, 'Reply', Respirology, vol. 19, pp. 769 - 770, http://dx.doi.org/10.1111/resp.12300
    Journal articles | 2013
    Dr Anthony Luke Byrne
    Byrne AL; Bennett MH; Pace NL; Thomas P, 2013, 'Peripheral venous blood gas analysis versus arterial blood gas analysis for the diagnosis of respiratory failure and metabolic disturbance in adults', Cochrane Database of Systematic Reviews, vol. 2013, http://dx.doi.org/10.1002/14651858.CD010841
    Journal articles | 2013
    Dr Anthony Luke Byrne
    Huang S; Byrne A; Dimitri A; Thomas PS, 2013, 'RESPIRATORY PRESENTATIONS OF STRONGYLOIDIASIS IN A LOW PREVALENCE SETTING', RESPIROLOGY, vol. 18, pp. 82 - 82, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2009
    Dr Anthony Luke Byrne
    Parker GB; Brotchie H, 2009, 'Reply', ACTA Psychiatrica Scandinavica, vol. 20, pp. 503 - 503
  • Conference Papers | 2012
    Dr Anthony Luke Byrne
    Byrne AL; Goldberg H; Mckenzie D, 2012, 'BRONCHOSCOPY WITH BRONCHIAL LAVAGE VERSUS SPUTUM FOR THE DIAGNOSIS OF SMEAR NEGATIVE MYCOBACTERIUM TUBERCULOSIS', in RESPIROLOGY, WILEY-BLACKWELL, pp. 83 - 83, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000301120800316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Awards

Grants

Past 5 Years


1) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. PhD scholarship. (2014-2015).Chronic Respiratory Disease among Successfully Treated Tuberculosis Patients of Lima, Peru. Byrne AL, Marais BJ, Marks GB. $50,000.


2) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. Seed Funding. (2014). Byrne AL, Marais BJ, Mitnick CD, Marks GB. Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis. A population-based cohort study in Lima, Peru. $25,000.


3) University of Sydney Postgraduate Research Support Scheme (2014, 2015). Byrne AL. Pulmones Post TB (Lungs after tuberculosis). Project support $12,000.


4) Woolcock Institute of Medical Research Fund (2015, 2016). Byrne AL. Marais BJ, Marks GB “Pulmones Post TB” (Lungs after tuberculosis). Project support $15,000.


5) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. Seed Funding. (2017). Byrne AL, Marais BJ, Marriott D. The use of therapeutic drug monitoring to improve clinical outcomes for patients with pulmonary tuberculosis; a pilot study. $25,000

Media